Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02168062 · ClinicalTrials.gov registry record · Phase 2
Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer
A Phase 2 study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- Phase 2
- Development phase
- 57
- Enrollment target
NCT02168062 is a Phase 2 study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 57 participants.
The verdict
NCT02168062, a Phase 2 study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 57 participants
- Enrollment target
Study Summary
This pilot partially-randomized phase II trial studies how well Supportive Therapy in Androgen Deprivation (STAND) clinic works in improving health outcomes and managing side effects in patients with prostate cancer. Individualized counseling regarding exercise and dietary habits may help improve patient understanding, satisfaction, and overall lessen adverse impact on quality of life caused by androgen deprivation.
Interventions
- OTHER Educational Intervention
- BEHAVIORAL Exercise Intervention
- DRUG Goserelin Acetate
- OTHER Counseling
- BEHAVIORAL Behavioral Dietary Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2014-06-16 |
| Est. Completion | 2018-05-22 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02168062
The ClinicalTrials.gov registry entry for NCT02168062 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Educational Intervention is the first listed.
NCT02168062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02168062 about?
NCT02168062 is a clinical study titled "Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer". This pilot partially-randomized phase II trial studies how well Supportive Therapy in Androgen Deprivation (STAND) clinic works in improving health outcomes and managing side effects in patients with prostate cancer. Individualized counseling regarding exercise and dietary habits may help improve pa...
What is the current status of trial NCT02168062?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 57 participants. The study started on 2014-06-16. Estimated completion is 2018-05-22.
What interventions are being tested in trial NCT02168062?
The interventions under investigation include: Educational Intervention (OTHER), Exercise Intervention (BEHAVIORAL), Goserelin Acetate (DRUG), Counseling (OTHER), Behavioral Dietary Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02168062?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.